G LNK

What do they actually do

G LNK provides a single SaaS platform for life‑sciences companies to discover and engage clinicians, analyze markets, and manage compliance. It bundles three modules: Sales Copilot for field targeting, call prep/capture, and CRM sync; Market Analytics for sizing, forecasting, and competitive benchmarks; and Compliance Hub for fair‑market‑value (FMV) calculations, approval routing, and Sunshine/EFPIA reporting (Sales Copilot, Market Analytics, Compliance Hub). Clinicians can also join a free HCP network (Connect+) so they can be discovered for consulting, speaking, research, and funding opportunities (HCPs / Connect+).

The product combines public data, proprietary signals (e.g., clinician CVs and digital engagement), and customer systems (CRM, CTMS) into a data graph that powers recommendations and reports (Homepage / Data sources). Day to day, reps get AI‑prioritized targets and call talking points, capture and transcribe conversations, and have notes/tasks synced back to their CRM; analysts run sizing and forecasts and push segments to the field; compliance teams generate FMV benchmarks and ready‑to‑file transparency reports with audit traces (Sales Copilot, Market Analytics, Compliance Hub). Copilot summaries and transcripts are processed by G LNK on behalf of customers per their configuration (Privacy Policy).

Who are their target customer(s)

• Field sales representative at a medtech or pharma company: They struggle to find and prioritize the right clinicians and accounts, and spend time preparing for calls and re‑entering notes into CRM systems.
• Market‑access or strategy analyst at a life‑sciences company: They need accurate, drill‑down market sizing, forecasts and competitive benchmarks but currently pull from many sources and stitch reports manually.
• Compliance officer or legal lead in pharma/medtech: They manage FMV calculations, approval routing, and Sunshine/EFPIA reporting with spreadsheets and limited audit trails, risking errors and rework.
• Medical affairs / KOL engagement manager: They must discover and verify clinicians for consulting, speaking and research, but clinician discovery is fragmented and slow.
• Clinical‑trial or site‑engagement manager: They need to identify investigators/sites and keep outreach aligned with CTMS/CRM, but data is siloed and recruiting is slow.

How would they acquire their first 10, 50, and 100 customers

• First 10: Run hands‑on pilots with small/mid‑sized medtech and pharma teams to replace manual workflows (targeting, call prep/capture with CRM sync, or FMV reporting) and quantify time saved and compliance gains; founders lead onboarding and support to produce the first case study and ROI metric.
• First 50: Use early case studies and referrals to sell into adjacent accounts via targeted outbound and short, workflow‑specific demos; host webinars showing a live target→call→CRM sync→report flow and offer a standard CRM/CTMS integration path to shorten procurement.
• First 100: Hire dedicated enterprise AEs and a CS engineer, standardize pilot contracts and integration templates, and add referral partners (CROs, commercial consultants, compliance firms). Expand the HCP network via targeted clinician recruitment and convert repeatable pilots into annual contracts with clear SLAs and audit evidence.

What is the rough total addressable market

Top-down context:

Adjacent markets suggest a large opportunity: sales‑enablement platforms (~$5.2B, 2024), pharma/life‑sciences CRM (~$4.4B, 2024), life‑science analytics (~$10.6B, 2024), and healthcare compliance software (~$2.8B, 2022). These categories overlap, so a de‑duplicated, near‑term TAM for an integrated platform like G LNK is roughly $8–12B (Grand View Research – Sales Enablement, AWS/CMI – Pharma CRM, ResearchAndMarkets – Life‑Science Analytics, Grand View Research – Healthcare Compliance).

Bottom-up calculation:

Assume ~3,500–5,000 global pharma/biotech/medtech/CRO buyers with commercial/medical teams, each with ~$1.6–2.4M/yr in combined budgets for field enablement, analytics, and compliance software that could be consolidated by a unified platform; this implies ~$5.6–12.0B in reachable spend.

Assumptions:

• 3,500–5,000 organizations worldwide have material commercial/medical operations and procurement capacity for these tools.
• Average buyer consolidates ~$1.6–2.4M/yr of overlapping enablement, analytics, and compliance software into a unified platform over time.
• Geographic coverage expands beyond the U.S./EU to reach global budgets as product adds integrations and compliance coverage.

Who are some of their notable competitors

• IQVIA: Enterprise data and analytics for life sciences, including provider/HCO reference data and commercial analytics (market sizing, forecasting, next‑best actions) that overlap with Market Analytics and Sales Copilot (IQVIA OneKey, IQVIA Commercial Analytics).
• Veeva Systems: Life‑sciences CRM and HCP reference data (OpenData) with field call capture/reporting, directly competing with Sales Copilot and G LNK’s HCP data/integration angle (Veeva CRM, Veeva OpenData).
• H1: HCP/KOL discovery and expert network for investigator/site selection and expert engagement, overlapping with Connect+ and parts of Market Analytics (H1 HCP Universe, H1 Platform).
• Clarify Health: Provider‑level analytics, demand forecasting and performance insights (claims‑based market sizing/forecasting) that compete with Market Analytics for launch planning and territory design (Clarify Platform, Clarify Life Sciences).
• Doximity: Large U.S. clinician network used for outreach, marketing, and talent; competes on clinician discovery and routed outreach to HCPs, overlapping with the HCP profile/network aspect (Doximity Directory, Doximity Marketing & Talent).